ZOOMCAR HOLDINGS INC (ZCAR)

US45784G1013 - Common Stock

6.51  -0.47 (-6.73%)

After market: 6.4528 -0.06 (-0.88%)

Fundamental Rating

1

Overall ZCAR gets a fundamental rating of 1 out of 10. We evaluated ZCAR against 38 industry peers in the Ground Transportation industry. ZCAR has a bad profitability rating. Also its financial health evaluation is rather negative. ZCAR has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year ZCAR was profitable.
In the past year ZCAR has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of ZCAR (44.72%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 44.72%
ROE N/A
ROIC N/A
ROA(3y)-125.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZCAR's Profit Margin of 52.45% is amongst the best of the industry. ZCAR outperforms 100.00% of its industry peers.
ZCAR does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 52.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

ZCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZCAR has been reduced compared to 1 year ago.
ZCAR has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -66.68, we must say that ZCAR is in the distress zone and has some risk of bankruptcy.
ZCAR has a worse Altman-Z score (-66.68) than 97.37% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -66.68
ROIC/WACCN/A
WACC5.26%

2.3 Liquidity

ZCAR has a Current Ratio of 0.11. This is a bad value and indicates that ZCAR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ZCAR (0.11) is worse than 97.37% of its industry peers.
ZCAR has a Quick Ratio of 0.11. This is a bad value and indicates that ZCAR is not financially healthy enough and could expect problems in meeting its short term obligations.
ZCAR has a worse Quick ratio (0.11) than 97.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 4482.98% over the past year.
EPS 1Y (TTM)4482.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3259.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.87 indicates a rather cheap valuation of ZCAR.
Based on the Price/Earnings ratio, ZCAR is valued cheaper than 100.00% of the companies in the same industry.
ZCAR is valuated cheaply when we compare the Price/Earnings ratio to 28.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.87
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZCAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZOOMCAR HOLDINGS INC

NASDAQ:ZCAR (11/21/2024, 5:53:43 PM)

After market: 6.4528 -0.06 (-0.88%)

6.51

-0.47 (-6.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.95M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 0.87
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 44.72%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 52.45%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)4482.98%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y